Reply to R.C. Turkington et al.

[1]  C. Harrison,et al.  Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Fredrik Mattsson,et al.  Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  P. Maxwell,et al.  Bone marrow micrometastases in esophageal carcinoma: a 10-year follow-up study. , 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[4]  O. Hoekstra,et al.  FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review , 2011, Annals of surgical oncology.

[5]  N. Altorki,et al.  Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy: A Multinational Study on the Significance of the Number of Involved Lymph Nodes , 2008, Annals of surgery.

[6]  Wolfgang A Weber,et al.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. , 2007, The Lancet. Oncology.

[7]  J. Lagergren,et al.  Survival after surgery for oesophageal cancer: a population-based study. , 2005, The Lancet. Oncology.

[8]  P. Devitt,et al.  Postoperative mortality following oesophagectomy and problems in reporting its rate , 2004, The British journal of surgery.

[9]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[10]  K. Hess,et al.  Treatment Outcomes of Resected Esophageal Cancer , 2002, Annals of surgery.

[11]  B. Cesana,et al.  Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. , 2001, Surgery.